Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in prec... Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.08 | 6.55737704918 | 1.22 | 1.3 | 1.19 | 220942 | 1.25505539 | CS |
| 4 | 0.15 | 13.0434782609 | 1.15 | 1.3 | 1.07 | 258983 | 1.21204482 | CS |
| 12 | -1.56 | -54.5454545455 | 2.86 | 2.99 | 0.726041 | 792779 | 1.43158493 | CS |
| 26 | -0.82 | -38.679245283 | 2.12 | 3.17 | 0.726041 | 419241 | 1.6386253 | CS |
| 52 | -0.42 | -24.4186046512 | 1.72 | 4.2684 | 0.726041 | 287355 | 1.96377671 | CS |
| 156 | -0.84 | -39.2523364486 | 2.14 | 4.2684 | 0.726041 | 147434 | 1.8625477 | CS |
| 260 | -1.34 | -50.7575757576 | 2.64 | 5.7 | 0.726041 | 405434 | 2.80770649 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
